Corcept Therapeutics Incorporated
0I3Q.L
Price:
$72.03
Market Cap:
$7.57B
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It is developing relacorilant to treat patients with Cushing's syndrome; and nab-paclitaxel in combination with relacorilant, which has completed Phase II clinical trial to treat patients with advance...[Read more]
Industry
Medical - Pharmaceuticals
IPO Date
2018-01-29
Stock Exchange
LSE
Ticker
0I3Q.L
PE Ratio
[78.81]
ROE
[20.46%]
Current Ratio
[3.07]
Dividend Yield
[0%]
Enterprise Value
[7.49B]
Dividend History
The ROE as of July 2025 (TTM) for Corcept Therapeutics Incorporated (0I3Q.L) is 20.46%
According to Corcept Therapeutics Incorporated’s latest financial reports and current stock price. The company's current ROE is 20.46%. This represents a change of 295.25% compared to the average of 5.18% of the last 4 quarters.
Corcept Therapeutics Incorporated (0I3Q.L) Historical ROE (quarterly & annually)
How has 0I3Q.L ROE performed in the past?
The mean historical ROE of Corcept Therapeutics Incorporated over the last ten years is 21.73%. The current 20.46% ROE has changed -5.85% with respect to the historical average. Over the past ten years (40 quarters), 0I3Q.L's ROE was at its highest in in the December 2017 quarter at 51.49%. The ROE was at its lowest in in the June 2015 quarter at -16.80%.
Average
21.73%
Median
20.75%
Minimum
-34.64%
Maximum
67.61%
Corcept Therapeutics Incorporated (0I3Q.L) ROE by Quarter and Year
Discovering the peaks and valleys of Corcept Therapeutics Incorporated ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 243.71%
Maximum Annual ROE = 67.61%
Minimum Annual Increase = -156.79%
Minimum Annual ROE = -34.64%
| Year | ROE | Change |
|---|---|---|
| 2024 | 20.56% | -1.84% |
| 2023 | 20.95% | 3.65% |
| 2022 | 20.21% | -32.50% |
| 2021 | 29.94% | 47.80% |
| 2020 | 20.26% | -20.17% |
| 2019 | 25.37% | -7.17% |
| 2018 | 27.33% | -59.57% |
| 2017 | 67.61% | 243.71% |
| 2016 | 19.67% | -156.79% |
| 2015 | -34.64% | -103.74% |
Corcept Therapeutics Incorporated (0I3Q.L) Average ROE
How has 0I3Q.L ROE performed in the past?
The current ROE of Corcept Therapeutics Incorporated (0I3Q.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
20.57%
5-year avg
22.38%
10-year avg
21.73%
Corcept Therapeutics Incorporated (0I3Q.L) ROE vs. Peers
How is 0I3Q.L’s ROE compared to its peers?
Corcept Therapeutics Incorporated’s ROE is
| Company | ROE | Market cap |
|---|
Build a custom stock screener for Corcept Therapeutics Incorporated (0I3Q.L) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Corcept Therapeutics Incorporated using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Corcept Therapeutics Incorporated (0I3Q.L) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Corcept Therapeutics Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Corcept Therapeutics Incorporated's ROE?
How is the ROE calculated for Corcept Therapeutics Incorporated (0I3Q.L)?
What is the highest ROE for Corcept Therapeutics Incorporated (0I3Q.L)?
What is the 3-year average ROE for Corcept Therapeutics Incorporated (0I3Q.L)?
What is the 5-year average ROE for Corcept Therapeutics Incorporated (0I3Q.L)?
How does the current ROE for Corcept Therapeutics Incorporated (0I3Q.L) compare to its historical average?